Senior Analytics Engineer, Color
$145-190k
Office located in Burlingame/South San Francisco, CA
Virtual cancer clinic focused on early detection, treatment and care
Open for applications
Virtual cancer clinic focused on early detection, treatment and care
501-1000 employees
Open for applications
$145-190k
Office located in Burlingame/South San Francisco, CA
501-1000 employees
Company mission
To reinvent how cancer care is delivered by bringing together engineering, design, science, and clinical expertise at every step of the journey.
Jump to section
Company mission
To reinvent how cancer care is delivered by bringing together engineering, design, science, and clinical expertise at every step of the journey.
Our take
Cancer care today is often fragmented, slow, and hard to access, so people are facing long waits for things like screenings, delays between diagnosis and treatment and confusing handoffs between providers. Because of this, cancers are often caught later than they should be, some care gaps go unaddressed, and patients are left to navigate an overwhelming system on their own. And for employers and health plans, this also drives higher costs and poorer outcomes across their populations.
Color has stepped in to act as a single partner across the entire cancer journey, from screening to treatment to survivorship. Led by oncologists, Co,or focuses on three simple ideas: making care easier to access, moving faster, and providing direct clinical support. Through at-home, guideline-based screening and proactive outreach, Color helps identify high-risk individuals and catch cancer earlier. Its clinical team works directly with patients to reduce barriers, close care gaps, and coordinate timely diagnosis and treatment, so people aren't left to figure things out on their own.
This approach is showing strong results too. Color drives high enrollment, significantly improves screening adherence, and cuts the time it takes for patients to get diagnosed and treated. By closing care gaps and supporting people through treatment and beyond, it improves outcomes while also lowering overall costs. With this success, the company is in a good position to keep redefining cancer care by scaling model that's faster, more accessible, and centered on real human needs.
Steph
Company Specialist at Welcome to the Jungle
Funding (last 2 of 6 rounds)
Nov 2021
$100m
SERIES E
Jan 2021
$167m
SERIES D
Total funding: $482m
This company has top investors
Leadership
Othman Laraki
(Co-Founder & CEO)After an MBA at MIT, they worked at Google as a Product Manager for almost 4 years, prior to co-founding Mixer Labs and working at Twitter and Pinterest. They left this Board role at ESI Group in 2012 to co-found Color in March 2013.
Rebecca Miksad
(CMO)Rebecca is the founder and CEO of Miksad MD Consulting and an Associate Professor of Medicine at Boston University School of Medicine. Alongside this, she is also an Associate Editor of RWE, RWD and Oncology for Clinical Pharmacology & Therapeutics (CPT) Journal at the American Society for Clinical Pharmacology & Therapeutics.
Joshua Sturm
(CRO)Prior to joining Color in 2024, Joshua spent over 4 years at Hinge Health, joining as VP of Partnerships & Business Development before moving into the role of VP of New Market development. Before that, he was VP of Key Accounts (Health Plans) at Surescripts and also spent nearly 14 years at Express Scripts, holding various roles including Director of Account Management and Senior Director of Strategic Relations.
Stephan Meyer-Ewald
(CPO)Prior to joining COlor in 2022, Stephan was the VP, Head of People at Roblox and SmartThings. He also spent 9 years at Google as a Director of People Operations and Project Director.
Dany Matar
(COO)Dany joined COlor in 2019 working in Strategic Partnerships, since then he has held a number of roles and moved into the role of COO in 2025. Prior to Color, he was an Engagement Manager at McKinsey & Company.